A restrictive harness, on the other hand, restricts the movement of the front limb, often by sitting over the shoulder joint, usually in the form of a straight band of the harness crossing in front of the dog
GLP-1 for sleep apnea, alcohol use and cancer risk GLP-1s may address conditions well beyond metabolic diseases: Obstructive sleep apnea: Emerging data suggest GLP-1s improve apnea symptoms. Alcohol use disorder: Patients using liraglutide or semaglutide reduced alcohol consumption by nearly two-thirds. Obesity-related cancers: An observational study of 6,000 adults found that GLP-1 receptor agonists halved the risk of obesity-related cancers compared with usual care
Discuss with your provider before your reauthorization date
Common side effects include: Nausea and Vomiting: The delayed gastric emptying that supports weight loss can lead to discomfort if portions are too large or meals are poorly timed
In the SURMOUNT-1 trial of tirzepatide, participants on the 15 milligram dose lost an average of 20.9 percent of their body weight over 72 weeks, while the STEP 1 trial of once-weekly semaglutide reported about 14.9 percent over 68 weeks